Indivior Provides Full-Year 2026 Financial Guidance and Business Update GlobeNewswire January 08, 2026 Total Net Revenue Expected in the Range of $1,125 million to $1,195 million Total SUBLOCADE(R) Net Revenue Expected to be in the Range of $905 million to $945 million Non-GAAP Operating Expenses Expected in the Range of $430 million to $450 million […]

Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases GlobeNewswire January 08, 2026 — Company on track to report ELEVATE-44-201 data from the first cohort in Q2 2026 and ELEVATE-45-201 data from the first cohort in mid-2026 – — Expects to initiate global Phase 1/2 MAD

Lexeo Therapeutics Announces Research Collaboration to Explore Targeted Cardiac Delivery of AAV Gene Therapy GlobeNewswire January 08, 2026 Collaboration will combine Lexeo expertise in cardiac genetic medicine with Johnson & Johnson's expertise in cardiovascular therapeutics and circulatory technologies, including Impella(TM) heart pumps Agreement will enable accelerated development of a preclinical cardiac target using novel, localized

AAVantgarde to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 08, 2026 LONDON and MILAN, Jan. 08, 2026 (GLOBE NEWSWIRE) — AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering therapies for inherited retinal diseases (IRDs), today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference, taking place January

Tisento Therapeutics Completes Enrollment in PRIZM, a Global Phase 2b Study of Zagociguat for the Treatment of MELAS Company Expects to Report Topline Data in Q4 2026 GlobeNewswire January 08, 2026 CAMBRIDGE, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) — Tisento Therapeutics today announced that the global Phase 2b PRIZM study is fully enrolled. PRIZM is

(TSX:FURY),(NYSE MKT:FURY), TORONTO, Jan. 08, 2026 (GLOBE NEWSWIRE) — Fury Gold Mines Limited (TSX: FURY, NYSE American: FURY) (“Fury” or the “Company“) is pleased to provide a review of 2025 corporate and technical achievements, including exploration drilling across four gold properties (Eleonore South, Sakami, Committee Bay and Eau Claire), meaningful portfolio expansion in Quebec via

Fury Reviews 2025 Achievements and Outlines 2026 Exploration Priorities Continues winter drilling program at Eau Claire GlobeNewswire January 08, 2026 TORONTO, Jan. 08, 2026 (GLOBE NEWSWIRE) — Fury Gold Mines Limited (TSX: FURY, NYSE American: FURY) (“Fury” or the “Company“) is pleased to provide a review of 2025 corporate and technical achievements, including exploration drilling

(Euronext Growth Paris:ALLLN),(Madrid:LLN),(OTC US:LLEIF),(OTCQX:LLEIF),(Boerse Frankfurt – Freiverkehr:9TV), Madrid, 8th January.- Spanish technology services company Lleida.net (BME:LLN) (EPA:ALLLN) began 2026 with a total of 8,886 active clients, representing a 55.62% increase compared with 5,710 clients at the start of 2025, according to company data released today. This is the highest client growth rate ever registered by

Lleida.net Begins 2026 With a 55.62% Increase in Clients Driven by Regulatory Demand GlobeNewswire January 08, 2026 Madrid, 8th January.- Spanish technology services company Lleida.net (BME:LLN) (EPA:ALLLN) began 2026 with a total of 8,886 active clients, representing a 55.62% increase compared with 5,710 clients at the start of 2025, according to company data released today.

(TSX:EDR),(NYSE:EXK), VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) reports full year 2025 production of 6,486,661 silver ounces (“oz”) and 37,164 gold oz, and in combination with base metal production, a silver equivalent ( 1) (“AgEq”) production of 11.2 million oz. Fourth quarter